This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (19)
-
May 09, 2025 | Insight Japan IP court rejects Patent Cooperation Treaty claims in inventorship dispute
Sections: Intellectual Property
-
January 24, 2024 | Comment Comment: AbbVie, Cerevel Therapeutics could point to fragmented markets, different mechanisms of action for overlapping drugs
Sections: DealRisk® and Mergers and Acquisitions
-
November 20, 2017 | Official Statement Otsuka Pharmaceutical, Claris Lifesciences deal published by Mofcom for simple case review
Sections: DealRisk® and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login